Royalty Pharma plc RPRX
68.53 USD -0.78 (-1.13%)
Regular-session close
68.53 0.00 0.00%
After hours · Nov 16, 5:54 PM ET
68.34 Day range 70.00
37.31 52-week range 70.37
- YTD
- +77.34%
- 1 year
- +74.99%
Benzinga news
benzinga.com Here's How Much $100 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 15 years by 6.93% on an annualized basis producing an average annual return of 19.95%. Currently, Royalty Pharma has a market…benzinga.com Citigroup Maintains Buy on Royalty Pharma, Raises Price Target to $78 Citigroup analyst Geoff Meacham maintains Royalty Pharma (NASDAQ:RPRX) with a Buy and raises the price target from $70 to $78.
benzinga.com Royalty Pharma Q3 Adj. EPS $1.21 Beats $1.18 Estimate, Sales $690.000M Miss $796.528M Estimate Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.18 by 2.54 percent. This is a 3.42 percent increase over earnings of $1.17…
benzinga.com Here's How Much $100 Invested In Royalty Pharma 10 Years Ago Would Be Worth Today Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 10 years by 32.09% on an annualized basis producing an average annual return of 45.51%. Currently, Royalty Pharma has a market…
benzinga.com ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber…
